{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:05:22Z","timestamp":1790845522958,"version":"4.1.0"},"reference-count":50,"publisher":"Spandidos Publications","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.3892\/mmr.2015.3319","type":"journal-article","created":{"date-parts":[[2015,2,9]],"date-time":"2015-02-09T08:11:39Z","timestamp":1423469499000},"page":"4255-4261","source":"Crossref","is-referenced-by-count":11,"title":["Chloroform fraction of Euphorbia maculata has antiplatelet activity via suppressing thromboxane B2 formation"],"prefix":"10.3892","volume":"11","author":[{"given":"SE-UK","family":"KWON","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JI-YOON","family":"CHA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HOON-YEON","family":"LEE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MINGJIE","family":"XIN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SU-JEONG","family":"JI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DAE-KI","family":"KIM","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DO-SIM","family":"PARK","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MI-KYUNG","family":"PYO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YOUNG-MI","family":"LEE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2015,2,9]]},"reference":[{"key":"key20180108002251_b1-mmr-11-06-4255","first-page":"8","article-title":"The role of platelets in the development and complication of atherosclerosis","volume":"23","author":"Packham","year":"1986","journal-title":"Semin Hematol"},{"key":"key20180108002251_b2-mmr-11-06-4255","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1055\/s-0038-1657598","article-title":"Mechanisms initiating platelet thrombus formation","volume":"78","author":"Ruggeri","year":"1997","journal-title":"Thromb Haemost"},{"key":"key20180108002251_b3-mmr-11-06-4255","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1038\/nm1102-1227","article-title":"Platelets in atherothrombosis","volume":"8","author":"Ruggeri","year":"2002","journal-title":"Nat Med"},{"issue":"Suppl 3","key":"key20180108002251_b4-mmr-11-06-4255","doi-asserted-by":"crossref","first-page":"18S","DOI":"10.1378\/chest.124.3_suppl.18S","article-title":"Thrombin and platelet activation","volume":"124","author":"Brass","year":"2003","journal-title":"Chest"},{"key":"key20180108002251_b5-mmr-11-06-4255","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/S0140-6736(07)61356-7","article-title":"Prevention of cardiovascular disease in developing countries","volume":"370","author":"Lindholm","year":"2007","journal-title":"Lancet"},{"key":"key20180108002251_b6-mmr-11-06-4255","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1056\/NEJMra0801082","article-title":"Mechanisms of thrombus formation","volume":"359","author":"Furie","year":"2008","journal-title":"N Engl J Med"},{"key":"key20180108002251_b7-mmr-11-06-4255","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/clpt.2009.98","article-title":"New antithrombotic drugs","volume":"86","author":"Gross","year":"2009","journal-title":"Clin Pharmacol Ther"},{"key":"key20180108002251_b8-mmr-11-06-4255","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrd966","article-title":"Antithrombotic drug market","volume":"2","author":"Collins","year":"2003","journal-title":"Nat Rev Drug Discov"},{"key":"key20180108002251_b9-mmr-11-06-4255","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.ahj.2010.06.007","article-title":"Novel antiplatelet therapy","volume":"160","author":"Gaglia","year":"2010","journal-title":"Am Heart J"},{"key":"key20180108002251_b10-mmr-11-06-4255","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jstrokecerebrovasdis.2009.12.004","article-title":"Predictors of biochemical aspirin and clopidogrel resistance in patients with ischemic stroke","volume":"20","author":"Fong","year":"2011","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"key20180108002251_b11-mmr-11-06-4255","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.pharmthera.2011.01.011","article-title":"Aspirin resistance: effect of clinical, biochemical and genetic factors","volume":"130","author":"Fitzgerald","year":"2011","journal-title":"Pharmacol Ther"},{"key":"key20180108002251_b12-mmr-11-06-4255","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1038\/bjp.2008.151","article-title":"Future innovations in antiplatelet therapies","volume":"154","author":"Barrett","year":"2008","journal-title":"Br J Pharmacol"},{"key":"key20180108002251_b13-mmr-11-06-4255","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/nrd1198","article-title":"Antiplatelet therapy: in search of the \u2018magic bullet\u2019","volume":"2","author":"Jackson","year":"2003","journal-title":"Nat Rev Drug Discov"},{"key":"key20180108002251_b14-mmr-11-06-4255","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/j.jacc.2006.11.044","article-title":"Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives","volume":"49","author":"Angiolillo","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"key20180108002251_b15-mmr-11-06-4255","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1055\/s-2000-8648","article-title":"Coumarins and antiplatelet constituents from the root bark of Zanthoxylum schinifolium","volume":"66","author":"Tsai","year":"2000","journal-title":"Planta Med"},{"key":"key20180108002251_b16-mmr-11-06-4255","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.phrs.2006.09.009","article-title":"Antiplatelet and antithrombotic activities of essential oil from wild Ocotea quixos (Lam) Kosterm (Lauraceae) calices from Amazonian Ecuador","volume":"55","author":"Ballabeni","year":"2007","journal-title":"Pharmacol Res"},{"key":"key20180108002251_b17-mmr-11-06-4255","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jep.2011.02.025","article-title":"Antiplatelet effects of Cyperus rotundus and its component (+)-nootkatone","volume":"135","author":"Seo","year":"2011","journal-title":"J Ethnopharmacol"},{"key":"key20180108002251_b18-mmr-11-06-4255","doi-asserted-by":"crossref","first-page":"861786","DOI":"10.1155\/2013\/861786","article-title":"Relationship between platelet PPARs, cAMP levels, and P-Selectin expression: Antiplatelet activity of natural products","volume":"2013","author":"Fuentes","year":"2013","journal-title":"Evid Based Complement Alternat Med"},{"key":"key20180108002251_b19-mmr-11-06-4255","doi-asserted-by":"crossref","first-page":"e90699","DOI":"10.1371\/journal.pone.0090699","article-title":"Chlorogenic acid inhibits human platelet activation and thrombus formation","volume":"9","author":"Fuentes","year":"2014","journal-title":"PLoS One"},{"key":"key20180108002251_b20-mmr-11-06-4255","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1139\/v97-088","article-title":"Four new hydrolysable tannins and an acylated flavonol glycoside from Euphorbia maculate","volume":"75","author":"Yoshiaki","year":"1997","journal-title":"Can J Chem"},{"key":"key20180108002251_b21-mmr-11-06-4255","first-page":"184","article-title":"Comparison on mass fraction of total flavonoids and tannin of three kinds of herba Euphorbiae Humifusae and their antibacaterial activity in vitro","volume":"21","author":"Cao","year":"2012","journal-title":"Acta Agriculturae Boreali-Occidentalis Sinica"},{"key":"key20180108002251_b22-mmr-11-06-4255","first-page":"2584","article-title":"Determination of rutin and quercitrin in the antifungal extract from Euphorbia maculate","volume":"22","author":"Kuerbannisha","year":"2011","journal-title":"Lishizhen Medicine and Materia Medica Research"},{"key":"key20180108002251_b23-mmr-11-06-4255","first-page":"287","article-title":"Research on the total flavonoids\u2019 content and antioxidant activity of Euphorbia maculata and Euphorbia humifusae","volume":"33","author":"Liu","year":"2007","journal-title":"J Hunan Agr U Nat Sci"},{"key":"key20180108002251_b24-mmr-11-06-4255","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.brainres.2008.10.061","article-title":"Effects of KR-33028, a novel Na+\/H+ exchanger-1 inhibitor, on glutamate-induced neuronal cell death and ischemia-induced cerebral infarct","volume":"1248","author":"Lee","year":"2009","journal-title":"Brain Res"},{"key":"key20180108002251_b25-mmr-11-06-4255","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.thromres.2009.02.010","article-title":"Ginkgo biloba extract enhances antiplatelet and antithrombotic effects of cilostazol without prolongation of bleeding time","volume":"124","author":"Ryu","year":"2009","journal-title":"Thromb Res"},{"key":"key20180108002251_b26-mmr-11-06-4255","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1365-2141.1972.tb08800.x","article-title":"Preparation of suspensions of washed platelets from humans","volume":"22","author":"Mustard","year":"1972","journal-title":"Br J Haematol"},{"key":"key20180108002251_b27-mmr-11-06-4255","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.jep.2010.12.039","article-title":"Antiplatelet effect of Spatholobus suberectus via inhibition of glycoprotein IIb\/IIIa receptor","volume":"134","author":"Lee","year":"2011","journal-title":"J Ethnopharmacol"},{"key":"key20180108002251_b28-mmr-11-06-4255","first-page":"1123","article-title":"A critical role for extracellular protein disulfide isomerase during thrombus formation in mice","volume":"118","author":"Cho","year":"2008","journal-title":"J Clin Invest"},{"key":"key20180108002251_b29-mmr-11-06-4255","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1345\/aph.10381","article-title":"Antiplatelet agents for secondary prevention of ischemic stroke","volume":"35","author":"Majid","year":"2001","journal-title":"Ann Pharmacother"},{"key":"key20180108002251_b30-mmr-11-06-4255","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1093\/eurheartj\/ehq277","article-title":"Guidelines on myocardial revascularization","volume":"31","author":"Wijns","year":"2010","journal-title":"Eur Heart J"},{"key":"key20180108002251_b31-mmr-11-06-4255","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1161\/hs1201.100829","article-title":"Combination therapy with clopidogrel and aspirin: can the cure results be extrapolated to cerebrovascular patients?","volume":"32","author":"Albers","year":"2001","journal-title":"Stroke"},{"key":"key20180108002251_b32-mmr-11-06-4255","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.vph.2004.04.001","article-title":"Antiplatelet and antithrombotic activities of CP201, a newly synthesized 1,4-naphthoquinone derivative","volume":"41","author":"Jin","year":"2004","journal-title":"Vasc Pharmcol"},{"key":"key20180108002251_b33-mmr-11-06-4255","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S1471-4892(03)00007-9","article-title":"Platelet purinergic receptors","volume":"3","author":"Kunapuli","year":"2003","journal-title":"Curr Opin Pharmacol"},{"key":"key20180108002251_b34-mmr-11-06-4255","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/35051599","article-title":"Identification of the platelet ADP receptor targeted by antithrombotic drugs","volume":"409","author":"Hollopeter","year":"2001","journal-title":"Nature"},{"key":"key20180108002251_b35-mmr-11-06-4255","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1160\/TH07-11-0673","article-title":"P2 receptors, platelet function and pharmacological implications","volume":"99","author":"Gachet","year":"2008","journal-title":"Thromb Haemost"},{"key":"key20180108002251_b36-mmr-11-06-4255","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1586\/14779072.5.1.45","article-title":"Platelet P2 receptors: old and new targets for antithrombotic drugs","volume":"5","author":"Cattaneo","year":"2007","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"Suppl 1","key":"key20180108002251_b37-mmr-11-06-4255","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1538-7836.2009.03382.x","article-title":"New P2Y12 blockers","volume":"7","author":"Cattaneo","year":"2009","journal-title":"J Thromb Haemost"},{"key":"key20180108002251_b38-mmr-11-06-4255","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1527-3466.2007.00027.x","article-title":"Prasugrel: a novel thienopyridine antiplatelet agent. A review of preclinical and clinical studies and the mechanistic basis for its distinct antiplatelet profile","volume":"25","author":"Jakubowski","year":"2007","journal-title":"Cardiovasc Drug Rev"},{"key":"key20180108002251_b39-mmr-11-06-4255","first-page":"1124","article-title":"The absorption, distribution and excretion of a new antithrombotic and vasodilating agent, cilostazol, in rat, rabbit, dog and man","volume":"35","author":"Akiyama","year":"1985","journal-title":"Arzneimittelforschung"},{"key":"key20180108002251_b40-mmr-11-06-4255","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.jep.2010.02.003","article-title":"Antithrombotic effects of Danggui, Honghua and potential drug interaction with clopidogrel","volume":"128","author":"Li","year":"2010","journal-title":"J Ethnopharmacol"},{"key":"key20180108002251_b41-mmr-11-06-4255","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.bcmd.2005.12.014","article-title":"The intrinsic pathway of coagulation is essential for thrombus stability in mice","volume":"36","author":"Renn\u00e9","year":"2006","journal-title":"Blood Cell Mol Dis"},{"key":"key20180108002251_b42-mmr-11-06-4255","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jep.2006.11.005","article-title":"Anti-thrombotic effect of chronic oral treatment with Orbignya phalerata Mart","volume":"111","author":"Azevedo","year":"2007","journal-title":"J Ethnopharmacol"},{"issue":"Suppl 3","key":"key20180108002251_b43-mmr-11-06-4255","doi-asserted-by":"crossref","first-page":"1S","DOI":"10.1378\/chest.124.3_suppl.1S","article-title":"Thrombin: can\u2019t live without it; probably die from it","volume":"124","author":"Mann","year":"2003","journal-title":"Chest"},{"key":"key20180108002251_b44-mmr-11-06-4255","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1160\/TH09-03-0192","article-title":"Mechanisms of platelet activation: need for new strategies to protect against platelet-mediated atherothrombosis","volume":"102","author":"Jennings","year":"2009","journal-title":"Thromb Haemost"},{"key":"key20180108002251_b45-mmr-11-06-4255","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1677\/joe.0.0780435","article-title":"Thromboxane B2 and human parturition: concentrations in the plasma and production in vitro","volume":"78","author":"Mitchell","year":"1978","journal-title":"J Endocrinol"},{"key":"key20180108002251_b46-mmr-11-06-4255","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1055\/s-0037-1613242","article-title":"Inhibition of ADP-induced P-selectin expression and platelet-leukocyte conjugate formation by clopidogrel and the P2Y12 receptor antagonist AR-C69931MX but not aspirin","volume":"88","author":"Storey","year":"2002","journal-title":"Thromb Haemost"},{"key":"key20180108002251_b47-mmr-11-06-4255","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/j.1538-7836.2007.02866.x","article-title":"Reciprocal regulation of platelet responses to P2Y and thromboxane receptor activation","volume":"6","author":"Barton","year":"2008","journal-title":"J Thromb Haemost"},{"key":"key20180108002251_b48-mmr-11-06-4255","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/0090-6980(80)90114-8","article-title":"Measurement of thromboxane B2 in human plasma or serum by radioimmunoassay","volume":"20","author":"Viinikka","year":"1980","journal-title":"Prostaglandins"},{"key":"key20180108002251_b49-mmr-11-06-4255","first-page":"117","article-title":"Cellular adhesion: GPIIb\/IIIa as a prototypic adhesion receptor","volume":"9","author":"Plow","year":"1989","journal-title":"Prog Hemost Thromb"},{"key":"key20180108002251_b50-mmr-11-06-4255","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/ncpcardio0712","article-title":"Drug insight: antithrombotic therapy after percutaneous coronary intervention in patients with an indication or anticoagulation","volume":"3","author":"Helft","year":"2006","journal-title":"Nat Clin Pract Cardiovasc Med"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/mmr.2015.3319\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T19:24:48Z","timestamp":1566329088000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mmr.2015.3319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,9]]},"references-count":50,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2015,2,9]]},"published-print":{"date-parts":[[2015,6]]}},"alternative-id":["10.3892\/mmr.2015.3319"],"URL":"https:\/\/doi.org\/10.3892\/mmr.2015.3319","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,9]]}}}